Literature DB >> 2844596

Expression of sodium pump activities in BALB/c 3T3 cells transfected with cDNA encoding alpha 3-subunits of rat brain Na+,K+-ATPase.

Y Hara1, A Nikamoto, T Kojima, A Matsumoto, M Nakao.   

Abstract

The cDNAs encoding alpha 3-subunits of rat brain Na+,K+-ATPase and the neomycin resistance gene were incorporated into BALB/c 3T3 cells by the co-transfection method. Stably transformed cells were selected with 300 micrograms/ml of neomycin (G-418) for 6 weeks. Northern blot analysis using the 3'-non-translated region of the cDNA as a probe revealed that the alpha 3 mRNA appeared in transfected cells. Na+,K+-ATPase activity of the transfected cells was twice that of wild-type cells. Regarding ouabain sensitivity, the Na+,K+-ATPase showed two Ki values for ouabain (8 x 10(-8) and 4.5 x 10(-5) M) in transfected cells while wild-type cells displayed only the higher value. Ouabain sensitivity of Rb+ uptake also demonstrated two Ki values in the transfected cells (8 x 10(-8) and 4 x 10(-5) M) and a Ki in wild-type cells of 4 x 10(-5) M. It is concluded that alpha 3 is a highly ouabain-sensitive catalytic subunit of Na+,K+-ATPase. It is also suggested that ouabain sensitivity is exclusively determined by the properties of the alpha-subunit rather than the beta-subunit. This is the first report on the catalytic characteristics of the alpha 3 isoform of Na+,K+-ATPase.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2844596     DOI: 10.1016/0014-5793(88)80218-7

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  10 in total

1.  Thyroid hormone regulation of Na,K-ATPase subunit-mRNA expression in neonatal rat myocardium.

Authors:  J Melikian; F Ismail-Beigi
Journal:  J Membr Biol       Date:  1991-01       Impact factor: 1.843

2.  Thyroidal enhancement of rat myocardial Na,K-ATPase: preferential expression of alpha 2 activity and mRNA abundance.

Authors:  G G Gick; J Melikian; F Ismail-Beigi
Journal:  J Membr Biol       Date:  1990-05       Impact factor: 1.843

3.  Ouabain-resistant mutants of the rat Na,K-ATPase alpha 2 isoform identified by using an episomal expression vector.

Authors:  V Canfield; J R Emanuel; N Spickofsky; R Levenson; R F Margolskee
Journal:  Mol Cell Biol       Date:  1990-04       Impact factor: 4.272

4.  Expression of multiple Na+,K+-adenosine triphosphatase isoform genes in human hematopoietic cells. Behavior of the novel A3 isoform during induced maturation of HL60 cells.

Authors:  M Gilmore-Hebert; J W Schneider; A L Greene; N Berliner; C A Stolle; K Lomax; R W Mercer; E J Benz
Journal:  J Clin Invest       Date:  1989-07       Impact factor: 14.808

5.  Ouabain application to the round window of the gerbil cochlea: a model of auditory neuropathy and apoptosis.

Authors:  R A Schmiedt; H-O Okamura; H Lang; B A Schulte
Journal:  J Assoc Res Otolaryngol       Date:  2001-12-20

6.  Differential expression and enzymatic properties of the Na+,K(+)-ATPase alpha 3 isoenzyme in rat pineal glands.

Authors:  A W Shyjan; V Ceña; D C Klein; R Levenson
Journal:  Proc Natl Acad Sci U S A       Date:  1990-02       Impact factor: 11.205

7.  Identification of a region within the Na,K-ATPase alpha subunit that contributes to differential ouabain sensitivity.

Authors:  J R Emanuel; S Graw; D Housman; R Levenson
Journal:  Mol Cell Biol       Date:  1989-09       Impact factor: 4.272

Review 8.  Na,K-ATPase: isoform structure, function, and expression.

Authors:  J B Lingrel
Journal:  J Bioenerg Biomembr       Date:  1992-06       Impact factor: 2.945

9.  Functional expression of the alpha 2 and alpha 3 isoforms of the Na,K-ATPase in baculovirus-infected insect cells.

Authors:  G Blanco; Z J Xie; R W Mercer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-03-01       Impact factor: 11.205

10.  Transcriptomic changes triggered by ouabain in rat cerebellum granule cells: Role of α3- and α1-Na+,K+-ATPase-mediated signaling.

Authors:  Larisa V Smolyaninova; Alexandra A Shiyan; Leonid V Kapilevich; Alexander V Lopachev; Tatiana N Fedorova; Tatiana S Klementieva; Aleksey A Moskovtsev; Aslan A Kubatiev; Sergei N Orlov
Journal:  PLoS One       Date:  2019-09-26       Impact factor: 3.240

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.